Where do Sutro Biopharma's ratios come from?

Every ratio is computed from Sutro Biopharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Sutro Biopharma STRO Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Operating margin	-154.5%+230pp	-384.3%—	——	-190.3%-31.0pp
Net margin	-186.5%+180pp	-366.6%—	——	-175.9%-5.3pp
Efficiency
Asset turnover	0.4×+0.2×	0.1×-0.2×	0.4×+0.2×	0.2×0.0×
Liquidity
Current ratio	2×-0.6×	2.6×-1.9×	4.5×-0.8×	5.3×+0.1×
Per Share
Book value per share	-$15.59-370%	$5.76+132%	$2.49-41.9%	$4.28-21.9%
Valuation
Market capitalization	$489.66M+624%	$151.72M-42.0%	$261.73M-43.6%	$464.4M-32.5%
Price / sales	4.9×+3.9×	2.4×+0.7×	1.7×-5.1×	6.9×-4.3×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Sutro Biopharma.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Sutro Biopharma's ratios come from?: Every ratio is computed from Sutro Biopharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.